with DC infi ltration. There was no correlation between iNOS and p53 expression. The prognoses of patients whose tumors expressed iNOS were signifi cantly worse than those of patients whose tumors did not express iNOS. Multivariate analysis indicated iNOS expression was an independent prognostic factor. Conclusion: iNOS might be associated with tumor progression by stimulating angiogenesis and suppressing immune responses in gastric carcinoma.
L -citrulline conversion by NO synthase (NOS), and increased NOS expression was observed in bladder [6] and colorectal cancer [7] compared with normal tissues. Three enzyme classes of NOS, calcium-dependent endothelial (eNOS), neuronal or brain isoforms (nNOS), and calcium-independent inducible NOS (iNOS), have been identifi ed so far [8] , and iNOS is the strongest producer of NO. iNOS expression has been shown to be correlated with a poor prognosis in melanoma patients [9] , but little is known about the signifi cance of iNOS expression as a prognostic factor in gastric cancer.
In the current study, we examined iNOS expression in patients with advanced gastric cancer and investigated the relationship between its expression and both clinicopathologic fi ndings and patient prognoses. Furthermore, we compared these expressions with vascular endothelial growth factor (VEGF) expression, thought to be the most potent angiogenic factor, microvessel (MV) density, and dendritic cell (DC) infi ltration to evaluate the effect of iNOS on angiogenesis and immune responses in gastric carcinoma.
Patients and Methods

Patients
A total of 135 advanced gastric adenocarcinoma patients with serosal invasion who underwent curative gastrectomy at our institution between March 1976 and December 1995 were included in this study. The subjects included 72 male and 63 female patients with an age range of 24-91 years (mean, 60.6 years). The clinicopathologic fi ndings were determined according to the rules set forth by the Committee of the Japanese Society on Histological Classification of Gastric Cancer [10] . The criteria considered for curative resection were complete removal of a primary gastric tumor, dissection of the regional lymph nodes, and no remaining macroscopic tumors. These patients had no metastasis in the liver, peritoneum or in other distant organs at the time of surgery. No previous or concomitant primary cancers were present, and no patients received either chemotherapy or radiation therapy before surgery. All had either a distal partial, proximal partial or total gastrectomy with regional lymph node dissection to group 1 (D1), group 2 (D2), or group 3 (D3) with curative intent. None of the resection margins were positive for tumors.
Immunohistochemistry iNOS Expression
. Four-micrometer-thick sections were dewaxed in xylene, dehydrated in ethanol and then heated in a microwave oven (700 W) for 10 min to retrieve the antigens. Endogenous peroxidase was blocked by incubation of samples in 3% hydrogen peroxide in methanol. After washing with PBS, the samples were incubated overnight with anti-iNOS polyclonal antibody (Chemicon International, Temecula, Calif., USA; dilution, 1: 500) then incubated with Envision-labeled polymer reagent (Dako, Copenhagen, Denmark) for 60 min at room temperature; envisionlabeled polymer reagent is a peroxidase-labeled polymer conjugated to goat anti-rabbit and goat anti-mouse immunoglobulins in Tris-HCl buffer containing a carrier protein and anti-microbial agent. The reaction products were visualized with diaminobenzidine as the chromogen, and the sections were counterstained with hematoxylin. Normal rabbit IgG was used instead of the primary antibodies for negative controls. Immunoreactivity was graded as follows: +, more than 25% of the carcinoma cells were stained; -, no detectable expression or fewer than 25% of the carcinoma cells were stained.
p53 Protein Expression . Staining of p53 protein was performed using anti-p53 monoclonal antibody (BP-53; Novocastra Laboratories, Newcastle, UK) at a dilution of 1: 50. The stained sections were visualized on a computer display (Macintosh 7500/100; Apple, Cupertino, Calif., USA) through a color video camera module (XC-003; Sony, Tokyo, Japan) and color image freezer (AE-6905C; Atto, Tokyo, Japan) from a light microscope (VANOX-S; Olympus, Tokyo, Japan). The expression of p53 was assessed according to the percentage of immunoreactive cells in a total of 1,000 neoplastic cells. Immunoreactivity specifi c for p53 in individual tissue sections was considered positive if unequivocal staining of the nucleus was seen in more than 20% of tumor cells [11] .
VEGF Expression . The detection procedure for VEGF was performed using anti-VEGF polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, Calif., USA; dilution, 1: 200), which is raised against a synthetic peptide corresponding to amino acidic residues 1-20 of human VEGF and recognizes 165, 189, and 121 aminosplicing variants of VEGF. Normal rabbit IgG was used instead of the primary antibodies for negative controls. Smooth muscle served as a positive control because smooth muscle cells have been shown to express VEGF. Immunoreactivity was graded as follows: +, more than 10% of the carcinoma cells were stained; -, no detectable expression or fewer than 10% of the carcinoma cells were stained, as previously reported [12] .
MV Detection and Counting . The detection procedure for MVs was performed using anti-CD34 monoclonal antibody (Nichirei, Tokyo, Japan). A single MV was defi ned as brown immunostained endothelial cells separated from adjacent MVs, tumor cells, and other connective tissue elements. The counting procedure was described in our previously published study [13] . Briefl y, the stained sections were screened at ! 100 magnifi cation ( ! 10 objective lens and ! 10 ocular lens) under a light microscope (VANOX-S; Olympus, Tokyo, Japan) to identify the fi ve regions of the section with the highest MV number. Images were visualized on a computer display (Macintosh 7500/100) through a color video camera module (XC-003; Sony) and color image freezer (AE-6905C; Atto, Tokyo, Japan). MVs were counted at ! 200 magnifi cation ( ! 20 objective lens and ! 10 ocular lens), and the average MV numbers were recorded. The visualized area on the display was determined as 0.075 mm 2 . Two observers (S.T. and H.S.) did the counting, and the mean value was used for analysis. Large vessels with thick muscular walls were excluded from the counts. The lumen was not required for identifi cation of a vessel.
Detection and Counting of DCs . The detection procedure for DCs was performed using anti-S-100 protein monoclonal antibody (Nichirei; dilution, 1: 200). The numbers of DCs positive for S-100 protein were counted in primary tumors including adjacent gastric mucosa. The stained sections were screened at ! 100 magnifi cation ( ! 10 objective lens and ! 10 ocular lens) under a light microscope to identify the fi ve regions of the section with the highest DC num-bers. The method for measuring DC density was similar to that assessing the MV number. An abundance of peripheral nerves immunostained with the antibodies against S-100 sometimes made it diffi cult to distinguish the DCs; therefore, DCs were counted only in those tumor tissues and gastric mucosa from which peripheral nerves were absent. Two observers (S.T. and H.S.) did the counting, and the mean value was used for analysis. Patients were divided into two groups as follows: marked infi ltration, i.e. 1 15 DCs, and slight infi ltration, i.e. ! 15 DCs [12] .
Statistical Analysis
The association of factors was evaluated by the 2 test, and signifi cant differences among means were determined by Mann-Whitney U test. Differences among survival curves based on iNOS expression were examined by the generalized Wilcoxon's test, and survival curves were constructed by the Kaplan-Meier method. Multivariate analysis of prognostic factors related to overall survival was performed using the Cox proportional hazards model and a stepwise procedure. The accepted level of signifi cance was p ! 0.05. A Macintosh personal computer system (StatView software; Abacus Concepts, Berkeley, Calif., USA) was used for all statistical analyses.
Results
iNOS Expression and Clinicopathological Findings
Positive immunostaining for iNOS was observed in the cytoplasm of the carcinoma cells in 106 (78.5%) of 135 cases ( fi g. 1 ). iNOS expression was more frequent in undifferentiated gastric carcinoma than differentiated gastric carcinoma. However, expression did not correlate with any other clinicopathologic factors, such as lymph node metastasis, and lymphatic and blood vessel invasion ( table 1 ) .
Relationship between iNOS Expression, p53
Expression and VEGF Expression p53 expression was observed in the nuclei of carcinoma cells in 43 (40.6%) of 106 cases and did not correlate with iNOS expression ( table 2 ). VEGF was mainly localized in the cytoplasm of carcinoma cells. Tumor cells that were strongly immunopositive for VEGF were observed more often at the invasive front than in the center of the tumor. VEGF expression was detected in 37 (36.7%) tumors and was closely correlated with iNOS expression ( table 2 ) .
Relationship between iNOS Expression, MV Density, and DC Infi ltration
The MV counts ranged from 16 to 136.4, with a mean value of 42.5 8 17.8. Patients were divided into two groups, patients with high and low MV density, according to the MV counts, the cut-off value being 42.5 (the mean value for all patients). The percentages of patients with high MV density were 28.6 (n = 6), 29.5 (n = 18) and 66% (n = 35) in the VEGF-iNOS-, VEGF+ iNOS-or VEGF- 11 (78.6%) 3 (21.4%) NS = Not signifi cant. Except for age and tumor size, the numbers (percentages) of patients are given. a Differentiated, papillary or tubular adenocarcinoma; undifferentiated, poorly differentiated or undifferentiated adenocarcinoma, or signet ring cell carcinoma.
b Depth of invasion: t3, tumor has penetrated the serosa without invasion of adjacent structures; t4, tumor has invaded adjacent structures. 
Fig. 2.
Correlation between iNOS and VEGF expression and MV density. The percentage of patients with high MV density was higher in the VEGF+ iNOS+ group than in the other groups, and the differences were statistically signifi cant. iNOS+, and in VEGF+ iNOS+ patients, respectively ( fi g. 2 ). The percentage of patients with high MV density in the VEGF+ iNOS+ group was higher than that in the other groups, and the differences were statistically signifi cant. The numbers of DCs ranged from 1.8 to 44.4, with a mean value of 13.2 8 6.5. The percentages of patients with marked DC infi ltration were 52.4 (n = 11), 60.6 (n = 37) and 22.6% (n = 12) in the VEGF-iNOS-, VEGF+ iNOS-or VEGF-iNOS+, and VEGF+ iNOS+ groups, respectively ( fi g. 3 ). The percentage of patients with marked DC infi ltration in the VEGF+ iNOS+ group was lower than that in the other groups, and the differences were statistically signifi cant.
iNOS Expression and Prognosis
The 5-year survival rate was 47.2% in patients with iNOS-positive tumors and 75.9% in patients with iNOSnegative tumors, and this difference was statistically signifi cant ( fi g. 4 ). We employed Cox proportional hazards model and a stepwise procedure to assess whether iNOS expression represents an independent prognostic factor. The covariates included gender, age, histological classification, tumor size, depth of invasion, lymph node metas- tasis, lymphatic vessel invasion, blood vessel invasion, and iNOS expression. The results showed that tumor size, lymph node metastasis, and iNOS expression were independent prognostic factors ( table 3 ) .
We have previously shown that VEGF was an independent prognostic factor in advanced gastric cancer [12] ; therefore, we analyzed prognosis according to VEGF and iNOS expression. The 5-year survival rate was 90.2% in patients with both iNOS-and VEGF-negative tumors, 60.7% in patients with either iNOS-or VEGF-positive tumors, and 30.2% in patients with both iNOS-and VEGF-positive tumors, and the differences were statistically signifi cant ( fi g. 5 ).
Discussion
We have previously reported that angiogenesis and local immune responses evaluated by DC infi ltration into carcinoma tissues are involved in tumor progression and metastasis in gastric carcinoma [14] . Some reports have indicated an association between NO and angiogenesis [3, 4] and immune suppression [5] . Moreover, it has been reported that iNOS expression is more frequent in gastric carcinoma tissues than normal gastric mucosa [15] . These fi ndings encouraged us to perform the present investigation on the correlation between iNOS expression, MV density, and DC infi ltration in gastric carcinoma tissues.
iNOS expression was detected in 106 (78.5%) of 135 cases, and it was more frequent in patients with undifferentiated gastric carcinoma than differentiated gastric carcinoma. These results were consistent with those of a previous report [15] . iNOS expression was signifi cantly correlated with a poor prognosis, and multivariate analysis indicated that iNOS expression was an independent prognostic factor as well as tumor size and lymph node metastasis. We have previously demonstrated that VEGF is an independent prognostic factor in advanced gastric cancer [12] . In the current study, VEGF and iNOS expression was closely correlated with prognosis in patients with advanced gastric cancer. To the best of our knowledge, this is the fi rst report showing the signifi cance of iNOS expression as a prognostic factor in gastric carcinoma.
Malignant tumors are known to depend on neovascularization for growth and metastasis [16] . It has also been suggested that the degree of tumor angiogenesis is related to clinical outcomes in patients with breast carcinoma [17] , non-small-cell lung carcinoma [18] , gastric carcinoma [19] , esophageal carcinoma [20] , and colon carcinoma [21] . Angiogenesis is thought to be regulated by growth factors such as basic fi broblast growth factor, transforming growth factor-ß or platelet-derived growth factor secreted by host and tumor cells [16, 22, 23] . Of these regulators, VEGF is thought to be the major regulator of tumor angiogenesis. In fact, it has been reported that VEGF expression is correlated with tumor angiogenesis and prognosis in patients with gastric carcinoma [24] , breast carcinoma [25] , and non-small-cell lung carcinoma [26] . Recent studies have evidenced that p53, a tumor suppressor gene, might play a crucial role in the control of angiogenesis through regulation of the potent angiogenic inhibitors thrombospondin-1 or VEGF [27] [28] [29] . We have previously shown the close correlation between p53 expression, VEGF expression, and MV density in gastric cancer patients [11] , and in a study by Feng et al. [30] , high coincidental positive and negative immunostaining rates were found for p53, iNOS, and VEGF in gastric cancer tissues. Therefore, we were very interested in the correlation between iNOS expression, p53 expression, and VEGF expression. In the current study, iNOS expression was correlated with VEGF expression; however, iNOS expression was not correlated with p53 expression. In the study by Feng et al. [30] , both early and advanced gastric cancer patients were included, and p53 and iNOS expression were correlated with depth of invasion and lymph node metastasis, respectively, indicating that both p53 and iNOS expression were correlated with tumor progression. The absence of a correlation between p53 and iNOS expression in the current study may be explained by our study cohort, which comprised only patients with advanced gastric cancer. With respect to angiogenesis, the percentage of patients with high MV density in VEGF+ iNOS+ was higher than in the other groups; therefore, iNOS might be correlated with angiogenesis through upregulation of VEGF expression in gastric carcinoma. It has been reported that NO is also involved in immune dysfunctions in the host. Stanford et al. [31] reported that NO induced apoptosis of DCs, which are the strongest antigen-presenting cells and play a crucial role in the amplifi cation of immune responses by promoting antigen presentation, T-lymphocyte proliferation, and proinfl ammatory cytokine production. Functional impairment and decreased numbers of DCs have been reported [32] , and this defective DC function eventually affects prognosis and metastasis in carcinoma patients. In fact, a decreased number of DCs at the tumor site was correlated with a poor prognosis in gastric cancer patients [12] . As VEGF produced by human tumors inhibits the functional maturation of DCs from CD34+ precursors [33] , we have previously analyzed both DC infi ltration and VEGF expression in gastric carcinoma tissues and have found an inverse correlation [12] . In the current study, both VEGF and iNOS expression were strongly correlated with a reduced number of DCs in gastric cancer tissues. Therefore, we speculated that iNOS expression decreased the number of DCs through induction of DC apoptosis and induction of VEGF expression.
In conclusion, this study demonstrated that iNOS expression was correlated with disease progression and prognosis in patients with gastric carcinoma. iNOS might be correlated with angiogenesis through upregulation of VEGF expression in gastric carcinoma, and, moreover, with immune dysfunction as a result of decreased DCs through the induction of DC apoptosis and VEGF expression. Further studies on the mechanism of their regulation will probably offer a new approach to anticancer treatment.
